Cardiac resynchronization therapy in a patient with amyloid cardiomyopathy
- Resource Type
- Authors
- D Zizek; Igor Zupan; Marta Cvijic
- Source
- Acta Cardiologica. 68:335-337
- Subject
- Male
Left ventricular contraction
medicine.medical_specialty
Biopsy
medicine.medical_treatment
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy
Immunoglobulin Light-chain Amyloidosis
Internal medicine
Humans
Medicine
cardiovascular diseases
Aged
Skin
Chemotherapy
medicine.diagnostic_test
business.industry
Amyloidosis
General Medicine
medicine.disease
Echocardiography
Heart failure
cardiovascular system
Cardiology
Cardiomyopathies
Cardiology and Cardiovascular Medicine
business
Amyloid cardiomyopathy
Follow-Up Studies
- Language
- ISSN
- 0373-7934
0001-5385
Cardiac involvement in systemic light chain amyloidosis carries poor prognosis. Amyloid deposition in the myocardium can alter regional left ventricular contraction and cause dyssynchrony. Cardiac resynchronization therapy (CRT) is an effective treatment strategy for patients with advanced heart failure and echocardiographic dyssynchrony. We report a clinical and echocardiographic response of a patient with amyloid cardiomyopathy, treated with a combination of chemotherapy and CRT.